PHK
FATE icon

Point72 Hong Kong’s Fate Therapeutics FATE Stock Holding History

Point72 Hong Kong’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,663
Closed -$642K – 645
2022
Q3 		$642K Buy
28,663
+12,608
+79% +$364K 0.04% 663
2022
Q2 		$398K Buy
16,055
+11,421
+246% +$315K 0.03% 782
2022
Q1 		$180K Buy
+4,634
New +$179K 0.02% 999
2021
Q3 		– Sell
-928
Closed -$81K – 2131
2021
Q2 		$81K Buy
+928
New +$74.8K 0.01% 1365
2020
Q3 		– Sell
-470
Closed -$16K – 1285
2020
Q2 		$16K Buy
+470
New +$14K ﹤0.01% 923
2019
Q4 		– Sell
-169
Closed -$3K – 1241
2019
Q3 		$3K Sell
169
-80
-32% -$1.53K ﹤0.01% 841
2019
Q2 		$5K Buy
+249
New +$4.49K ﹤0.01% 927

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return